Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Dermatology
•
Drug Eruptions
How do you approach monitoring in DRESS or DiHS patients?
Which tests do you order and when do you re-order tests?
Related Questions
After corticosteroids, what second line agent do you select to treat drug induced hypersensitivity syndrome (also known as DRESS syndrome)?
In difficult cases, what is your approach to find a causative agent of fixed drug or fixed food eruption?
When would you pursue genetic testing for severe recalcitrant atopic dermatitis?
Are you comfortable utilizing Stelara (ustekinumab) as biologic treatment of psoriasis for patients with a history of severe latex allergy?
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?
How would you manage a patient with profound hyperpigmentation of the face and neck which is attributed to a post-COVID vaccine reaction?
How frequently or soon have you noticed TNF-a induced psoriasiform dermatitis develop?
Would you recommend continuing Accutane in a teenage female who has experienced a drop in calcium to 8.8 and reductions in albumin and protein levels one month into therapy?
How do you determine if a pyoderma gangrenosum lesion is “burned out"?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
